| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.
|
Cancer Res
|
2009
|
7.98
|
|
2
|
Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
|
Br J Haematol
|
2009
|
4.18
|
|
3
|
How basal are triple-negative breast cancers?
|
Int J Cancer
|
2008
|
3.18
|
|
4
|
Integrated profiling of basal and luminal breast cancers.
|
Cancer Res
|
2007
|
2.86
|
|
5
|
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
|
Cancer Res
|
2006
|
2.52
|
|
6
|
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
|
Cancer Res
|
2005
|
2.26
|
|
7
|
A gene expression signature identifies two prognostic subgroups of basal breast cancer.
|
Breast Cancer Res Treat
|
2010
|
2.03
|
|
8
|
Comprehensive profiling of 8p11-12 amplification in breast cancer.
|
Mol Cancer Res
|
2005
|
1.96
|
|
9
|
Prognosis and gene expression profiling of 20q13-amplified breast cancers.
|
Clin Cancer Res
|
2006
|
1.75
|
|
10
|
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
|
BMC Cancer
|
2006
|
1.58
|
|
11
|
Retinoid signaling regulates breast cancer stem cell differentiation.
|
Cell Cycle
|
2009
|
1.56
|
|
12
|
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
|
Genes Chromosomes Cancer
|
2012
|
1.47
|
|
13
|
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.
|
Cancer Res
|
2004
|
1.30
|
|
14
|
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
|
Cancer Res
|
2008
|
1.26
|
|
15
|
Kinome expression profiling and prognosis of basal breast cancers.
|
Mol Cancer
|
2011
|
1.22
|
|
16
|
How different are luminal A and basal breast cancers?
|
Int J Cancer
|
2009
|
1.15
|
|
17
|
Gene expression profiling and prediction of clinical outcome in ovarian cancer.
|
Crit Rev Oncol Hematol
|
2009
|
1.13
|
|
18
|
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
|
Stem Cells
|
2012
|
1.13
|
|
19
|
Gene expression profiling and clinical outcome in breast cancer.
|
OMICS
|
2006
|
1.10
|
|
20
|
Moesin expression is a marker of basal breast carcinomas.
|
Int J Cancer
|
2007
|
1.09
|
|
21
|
Loss, mutation and deregulation of L3MBTL4 in breast cancers.
|
Mol Cancer
|
2010
|
1.04
|
|
22
|
A gene signature in breast cancer.
|
N Engl J Med
|
2007
|
0.95
|
|
23
|
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
|
Haematologica
|
2012
|
0.86
|
|
24
|
ETV6 gene rearrangements in invasive breast carcinoma.
|
Genes Chromosomes Cancer
|
2005
|
0.85
|
|
25
|
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancer.
|
Cancer Genomics Proteomics
|
2011
|
0.84
|
|
26
|
[Prognostic classification of breast cancer and gene expression profiling].
|
Med Sci (Paris)
|
2008
|
0.76
|